Achieve Life Sciences, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ACHV Nasdaq 2830 www.achievelifesciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory - Feb 2nd, 2026 5:32 pm
Achieve Life Sciences Announced Granting of New Hire Inducement Awards - Jan 30th, 2026 2:05 pm
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near Future - Jan 17th, 2026 5:57 am
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer - Jan 12th, 2026 6:47 am
Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week - Dec 17th, 2025 2:01 pm
Institutions profited after Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) market cap rose US$48m last week but individual investors profited the most - Nov 29th, 2025 5:11 am
FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation - Nov 25th, 2025 6:40 am
ACHV: FDA’s CNPV Awarded for Vaping - Nov 10th, 2025 2:20 am
Achieve Life Sciences Inc (ACHV) Q3 2025 Earnings Call Highlights: Strategic Advances and ... - Nov 6th, 2025 2:01 pm
Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program - Nov 6th, 2025 5:00 am
Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation - Nov 3rd, 2025 6:30 am
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025 - Oct 29th, 2025 6:30 am
Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer - Oct 20th, 2025 6:30 am
FDA Grants First CNPV Vouchers, Igniting Rally in Biotech Stocks - Oct 20th, 2025 6:25 am
Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Expedites Review of Vaping Cessation Therapy - What's Changed - Oct 19th, 2025 7:12 am
A Look at Achieve Life Sciences's Valuation After FDA Priority Voucher for Cytisinicline Therapy - Oct 18th, 2025 3:08 am
The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. - Oct 17th, 2025 2:21 pm
Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation - Oct 17th, 2025 5:30 am
Achieve Life Sciences Announces Granting of New Hire Inducement Awards - Oct 2nd, 2025 2:01 pm
Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline’s Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD - Sep 22nd, 2025 6:30 am